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Dear Editors:
W
e offer a few comments regarding a recent article by
Mistry et al.1 published in this Journal entitled ‘‘Cri-
tical appraisal of published systematic reviews asses-
sing the cost-effectiveness of telemedicine studies.’’
Normally, we would not engage in comments as a rebuttal to a
published article, but this article puts forth misleading and unwar-
ranted conclusions at a critical period in the telemedicine policy
debate. At issue are the merits of telemedicine as a cost-effective
healthcare option. The authors repeatedly conclude or note a general
consensus in their selective review regarding the lack of evidence
for telemedicine cost-effectiveness, which may be interpreted as
telemedicine not being cost-effective. However, a closer examina-
tion reveals the inaccuracy of this interpretation and that it stems
from errors in logic and methodology. That is, in our view, the au-
thors’ conclusions about cost-effectiveness of telemedicine are not
supported.
There are serious problems with the approach taken in this article:
1. There is a methodological issue as to whether an assessment on
cost-effectiveness can be derived from a ‘‘review of reviews,’’
especially when the number of such reviews dwindles from over
4,000 initial reported abstracts to 9, only 3 of which covered the
last 5 years. Basically, a clinically based methodology is used to
index the quality of the reviews. The authors then presume to
make a valid assessment of cost-effectiveness findings based on
the determinations of review quality, such as it is. The question
is whether the index of review quality provides sufficient basis
for drawing conclusions about the bodies of information within
the selected reviews.
The authors’ challenge was to establish and apply an index
that captures the widely differing levels of scientific merit of
reviews so as to create a valid summary of cost-effectiveness
findings. This requires a measure that summarizes the study
findings on cost-effectiveness as these were reported through a
flawed lens of reviews applied across a broad range of study
designs and sample sizes. And often, these selected reviews are
themselves significantly flawed, especially in terms of internal
and external validity, as well as in defining uniform units of
analysis. Nonetheless, the authors of this article pursued this
problemby scoring review quality and veracity, applying a scale
derived from the work of Oxman and Guyatt.2 Then, the authors
further undermined a questionable assessment framework by
disregarding the framer’smethodology, such as assigning them-
selves (two of the authors) as the judges, rather than obtaining
independent rankings, and by trying to score the quality and
veracity of the reviews on a 7-point scale. Initially the scale had
nine items (p. 610). A ‘‘10th item collates the information from
the first nine items by having the assessor grade the review on an
ordinal scale ranging from 1 (minimal flaws) to 7 (extensive
flaws).’’ Based on this summary score, five reviews were rated as
7, one as 6, and two as 5, and one was rated best with a 4. Yet,
strangely enough, the rating scale is inverted on page 614, with
7 being minimal flaws.
2. Second, this article is conceptually flawed in the determination
of the scope of the analysis. The authors restricted their analysis
to ‘‘the general field of telemedicine’’ (p. 609), as opposed to
telemedicine studies defined by clinical application, techno-
logical configuration, provider mix, patient mix, and context.
For example, teleradiology and telemonitoringmay be excluded
from the analysis. The stated purpose of this approach is ‘‘to
make the results more generalizable’’ (p. 610). However, there
appears to be some confusion between the ‘‘generalization
of a technology’’ and the generalizability of results (i.e., exter-
nal validity). Consequently, the selected reviews incorporated
studies with technologically heterogeneous applications, which
often have differing impacts, costs, and contextual suitability.
And, the likely problem with evaluations focusing on ‘‘general
telemedicine’’ appears in the concluding discussion section
of the artcile. The authors’ argument for reviewing ‘‘general
telemedicine’’ seems to be undermined when they note the
‘‘. challenges in generalizability of the cost-effectiveness of
telemedicine due to the heterogeneous nature of the fields to
which telemedicine was applied’’ (p. 616).
Indeed, in studying telemedicine costs, in particular, it makes
little sense to view the entire field as a single or unidimensional
telemedicine intervention. Precise specifications of telemedicine
applications are often required to ascertain the production pro-
cess that makes the cost-effectiveness impacts of telemedicine
more discernible.
3. Finally, and perhaps most importantly, this article is an indict-
ment of the inadequatemethodologies used in systematic reviews
of cost-effectiveness for telemedicine. Systematic reviews in
Health Policy Systems Research (HPSR) provide summaries of
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scientific knowledge for policy and organizational decision-
making. But, the findings of these systematic reviews have been
incomplete because of the application of clinically oriented sys-
tematic review protocols. These clinically oriented systematic
reviews have not adequately dealt with the required HPSR study
information, such as findings on contextual impacts, sensitivity
to self-selection, fidelity of implementation, maturation, and
bundling along with the traditional methodological rigor, in-
cluding research design, sample size, frequency, and duration of
the study. With HPSR systematic reviews, methods have been
rapidly emerging over the last several years, but alas, the con-
clusions from the review of reviews discussed here depended
largely on applications of the older methodologies with signifi-
cant limitations when applied to the cost-effectiveness of
healthcare delivery innovations.
To summarize, this ‘‘review of reviews’’ applied weak or inappro-
priate tools in assessing selected studies and filtered out some of the
most important ones. The defined scope of the studies for review
eliminated important findings on cost-effectiveness. Moreover, al-
though this article focused on cost-effectiveness analysis, this is not
the only or optimal methodology for assessing the impacts of tele-
medicine applications, nor is it the only method for assessing eco-
nomic efficiency. For example, numerous studies have investigated
the impact of telemedicine interventions on the use of services, such
as hospital admissions/re-admissions, visits to the emergency room,
and length of hospital stay. Typically these studies are not catego-
rized as cost-effectiveness studies, but they add insight into the cost
issue. Finally, in the current state of methodological development, all
evidence from research studies must be viewed from the perspective
of the specific design features of the studies from which they derive,
and systematic reviews of findings must be based on actual studies,
not a derivative from other reviews.
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